0027

COM:CNKH

康弘药业

  • Stock

Last Close

20.05

22/11 07:04

Market Cap

20.19B

Beta: -

Volume Today

12.12M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
82.81M
-
92.40M
11.59%
108.93M
17.88%
130.22M
19.55%
160.54M
23.28%
213.99M
33.30%
258.61M
20.85%
251.39M
2.79%
267.63M
6.46%
313.29M
17.06%
367.29M
17.23%
average payables
50.51M
-
35.96M
28.81%
35.76M
0.55%
56.07M
56.79%
100.11M
78.55%
114.22M
14.09%
171.03M
49.74%
264.57M
54.69%
316.00M
19.44%
376.34M
19.09%
376.79M
0.12%
average receivables
98.39M
-
118.75M
20.69%
137.51M
15.80%
106.45M
22.59%
134.65M
26.50%
318.80M
136.76%
459.14M
44.02%
419.19M
8.70%
296.47M
29.27%
208.75M
29.59%
186.82M
10.51%
book value per share
1.76
-
2.04
15.99%
3.03
48.71%
3.33
9.69%
4.06
22.03%
4.70
15.74%
5.29
12.51%
6.61
25.00%
6.65
0.61%
7.54
13.39%
8.52
12.89%
capex per share
-0.10
-
-0.12
16.99%
-0.14
21.40%
-0.20
38.84%
-0.36
83.87%
-0.53
47.14%
-1.10
108.87%
-0.71
35.69%
-0.62
12.25%
-0.39
37.59%
-0.15
60.97%
capex to depreciation
-1.34
-
-1.35
0.83%
-1.79
32.06%
-2.68
50.18%
-4.80
78.85%
-6.19
29.13%
-10.35
67.08%
-5.21
49.69%
-3.81
26.80%
-2.24
41.12%
-0.62
72.20%
capex to operating cash flow
-0.23
-
-0.31
33.83%
-0.24
22.43%
-0.20
16.31%
-0.41
102.85%
-1.31
220.23%
-1.19
9.26%
-2.26
90.43%
-1.15
48.96%
-0.38
66.68%
-0.11
70.31%
capex to revenue
-0.05
-
-0.05
3.17%
-0.06
3.58%
-0.07
20.02%
-0.11
67.55%
-0.16
39.95%
-0.30
88.11%
-0.19
36.65%
-0.16
15.65%
-0.10
33.64%
-0.04
66.52%
cash per share
0.96
-
1.21
26.73%
2.05
68.88%
2.73
33.56%
3.56
30.03%
2.87
19.41%
2.61
8.89%
3.82
46.33%
3.43
10.24%
4.03
17.46%
5.12
27.06%
days of inventory on hand
170.93
-
197.27
15.41%
183.35
7.06%
220.50
20.26%
235.71
6.90%
405.84
72.18%
364.02
10.30%
265.27
27.13%
304.29
14.71%
311.32
2.31%
336.03
7.94%
days payables outstanding
83.01
-
62.17
25.10%
62.42
0.40%
110.23
76.60%
171.66
55.73%
162.59
5.28%
332.38
104.42%
319.77
3.79%
353.19
10.45%
385.23
9.07%
286.42
25.65%
days sales outstanding
22.89
-
31.58
37.94%
22.90
27.49%
11.89
48.07%
24.44
105.48%
56.43
130.93%
52.35
7.22%
41.11
21.48%
22.46
45.37%
21.08
6.14%
16.41
22.14%
debt to assets
0.00
-
0.00
37.62%
0.07
-
0.05
27.67%
0.03
34.75%
0.00
96.76%
0.00
37.37%
0.00
62.58%
debt to equity
0.01
-
0.00
38.42%
0.08
-
0.06
28.29%
0.04
37.06%
0.00
96.96%
0.00
38.67%
0.00
63.44%
dividend yield
0.00
-
0.01
45.31%
0.00
75.88%
0.00
35.11%
0.00
7.24%
0.01
238.48%
0.01
31.43%
0.01
0.30%
0.00
15.42%
0.01
29.76%
0.01
27.22%
earnings yield
0.04
-
0.04
13.38%
0.01
68.63%
0.01
14.99%
0.02
23.01%
0.03
95.13%
0.02
28.89%
-0.01
128.95%
0.02
451.10%
0.06
176.32%
0.06
1.18%
enterprise value
6.83B
-
6.63B
2.95%
33.06B
398.74%
35.74B
8.08%
37.09B
3.78%
20.07B
45.89%
30.29B
50.92%
38.59B
27.40%
15.70B
59.32%
10.78B
31.35%
12.23B
13.47%
enterprise value over ebitda
15.81
-
16.25
2.81%
62.94
287.26%
56.01
11.01%
43.09
23.08%
24.92
42.16%
35.04
40.62%
-96.17
374.44%
20.76
121.59%
9.81
52.75%
8.80
10.34%
ev to operating cash flow
20.49
-
22.75
11.02%
68.60
201.51%
42.22
38.45%
48.36
14.54%
57.19
18.26%
37.29
34.79%
141.18
278.57%
31.77
77.50%
11.65
63.34%
10.04
13.84%
ev to sales
4.63
-
3.96
14.42%
15.94
302.61%
14.07
11.73%
13.31
5.40%
6.88
48.32%
9.30
35.17%
11.71
25.93%
4.35
62.82%
3.18
26.97%
3.09
2.83%
free cash flow per share
0.33
-
0.26
21.49%
0.44
72.26%
0.77
74.45%
0.52
32.83%
-0.12
123.79%
-0.17
39.36%
-0.39
128.84%
-0.08
79.17%
0.62
857.22%
1.18
89.10%
free cash flow yield
0.03
-
0.03
21.49%
0.01
60.34%
0.02
68.33%
0.01
36.31%
-0.00
142.86%
-0.00
3.59%
-0.01
75.71%
-0.00
50.71%
0.04
1,082.12%
0.06
60.64%
graham net net
0.71
-
1.00
41.35%
1.78
78.40%
1.91
7.54%
2.62
37.03%
2.12
19.01%
1.78
16.06%
2.85
59.83%
2.84
0.15%
3.48
22.42%
4.70
35.09%
graham number
4.00
-
4.01
0.24%
5.71
42.34%
6.53
14.33%
8.22
25.82%
9.20
11.98%
9.89
7.53%
6.79
31.35%
8.30
22.19%
12.90
55.42%
14.78
14.59%
income quality
1.04
-
1.05
0.91%
1.21
15.19%
1.69
39.39%
1.19
29.66%
0.50
57.59%
1.13
123.96%
-1.01
189.57%
1.17
215.86%
1.07
8.94%
1.18
10.58%
intangibles to total assets
0.11
-
0.09
13.64%
0.07
24.21%
0.06
15.39%
0.08
39.86%
0.16
88.60%
0.22
44.41%
0.08
64.22%
0.05
37.02%
0.05
0.67%
0.05
5.84%
interest coverage
257.14
-
1.09K
323.54%
3.43K
215.37%
26.00
-
17.29
33.48%
-1.14K
-
-8.39
-
interest debt per share
0.01
-
0.01
36.67%
0.00
97.73%
0.03
-
0.45
1,187.28%
0.32
28.89%
0.25
21.15%
0.01
96.95%
-0.13
1,759.78%
0.00
101.73%
inventory turnover
2.14
-
1.85
13.35%
1.99
7.59%
1.66
16.84%
1.55
6.45%
0.90
41.92%
1.00
11.49%
1.38
37.23%
1.20
12.82%
1.17
2.26%
1.09
7.35%
invested capital
0.01
-
0.00
38.42%
0.08
-
0.06
28.29%
0.04
37.06%
0.00
96.96%
0.00
38.67%
0.00
63.44%
market cap
7.57B
-
7.57B
0.00%
34.75B
359.07%
38.12B
9.70%
40.19B
5.42%
22.22B
44.71%
32.29B
45.34%
41.91B
29.79%
18.63B
55.56%
14.36B
22.94%
16.93B
17.91%
net current asset value
611.06M
-
859.56M
40.67%
1.77B
105.34%
2.02B
14.61%
2.42B
19.68%
2.30B
4.92%
1.82B
20.98%
2.72B
49.34%
2.85B
4.83%
3.42B
19.94%
4.59B
34.33%
net debt to ebitda
-1.71
-
-2.31
34.81%
-3.21
39.33%
-3.74
16.41%
-3.60
3.66%
-2.67
25.87%
-2.32
13.10%
8.29
457.32%
-3.88
146.76%
-3.26
15.94%
-3.38
3.72%
net income per share
0.40
-
0.35
13.38%
0.48
36.24%
0.57
19.16%
0.74
29.73%
0.80
8.33%
0.82
2.78%
-0.31
137.70%
0.46
248.39%
0.98
113.04%
1.14
16.33%
operating cash flow per share
0.43
-
0.37
12.58%
0.58
56.50%
0.97
65.89%
0.88
9.36%
0.40
54.05%
0.93
130.18%
0.31
66.23%
0.54
71.92%
1.01
87.32%
1.33
31.48%
payables turnover
4.40
-
5.87
33.52%
5.85
0.40%
3.31
43.37%
2.13
35.79%
2.24
5.58%
1.10
51.08%
1.14
3.94%
1.03
9.46%
0.95
8.32%
1.27
34.50%
receivables turnover
15.94
-
11.56
27.51%
15.94
37.91%
30.69
92.56%
14.94
51.33%
6.47
56.70%
6.97
7.78%
8.88
27.36%
16.25
83.06%
17.32
6.54%
22.24
28.43%
research and ddevelopement to revenue
0.04
-
0.05
11.76%
0.05
6.27%
0.05
0.44%
0.07
43.13%
0.08
14.64%
0.09
11.56%
0.51
477.38%
0.28
45.01%
0.11
60.54%
0.11
3.45%
return on tangible assets
0.21
-
0.16
25.56%
0.15
5.97%
0.14
3.73%
0.15
8.99%
0.16
3.47%
0.16
0.34%
-0.04
126.37%
0.06
252.14%
0.12
91.92%
0.13
5.14%
revenue per share
1.89
-
2.15
13.40%
2.52
17.21%
2.91
15.68%
3.19
9.74%
3.36
5.14%
3.73
11.04%
3.79
1.52%
3.94
4.04%
3.70
5.96%
4.32
16.58%
roe
0.23
-
0.17
25.32%
0.16
8.38%
0.17
8.63%
0.18
6.31%
0.17
6.40%
0.16
8.66%
-0.05
130.16%
0.07
247.49%
0.13
87.89%
0.13
3.05%
roic
0.22
-
0.17
22.91%
0.15
9.93%
0.17
10.90%
0.19
11.14%
0.16
16.66%
0.14
7.85%
-0.05
134.65%
0.11
313.20%
0.12
16.02%
0.13
9.33%
sales general and administrative to revenue
0.09
-
0.07
18.41%
0.06
16.41%
0.07
16.69%
0.07
1.95%
0.08
14.00%
0.07
17.13%
0.09
34.85%
0.04
48.91%
0.04
2.05%
0.04
4.49%
shareholders equity per share
1.76
-
2.04
15.99%
3.03
48.71%
3.33
9.69%
4.06
22.03%
4.70
15.74%
5.29
12.51%
6.61
25.00%
6.65
0.61%
7.54
13.39%
8.52
12.89%
stock based compensation to revenue
tangible asset value
1.21B
-
1.43B
18.57%
2.32B
62.06%
2.68B
15.52%
3.17B
17.96%
3.28B
3.51%
3.31B
1.10%
5.19B
56.79%
5.75B
10.77%
6.51B
13.22%
7.40B
13.65%
tangible book value per share
1.55
-
1.84
18.56%
2.82
53.33%
3.07
9.13%
3.63
18.01%
3.77
3.94%
3.79
0.54%
5.97
57.33%
6.28
5.34%
7.12
13.27%
8.08
13.47%
working capital
707.49M
-
957.83M
35.38%
1.86B
94.24%
2.28B
22.74%
2.88B
26.31%
2.79B
3.17%
2.28B
18.43%
2.98B
30.90%
3.03B
1.65%
3.54B
16.63%
4.65B
31.56%

All numbers in (except ratios and percentages)